Skip to content
2000
Volume 18, Issue 6
  • ISSN: 2666-1454
  • E-ISSN: 2666-1462

Abstract

The naturally occurring, bioactive dietary flavonoid known as fisetin, also known as a tetrahydroxy flavone, is widely present in foods like apples, strawberries, grapes, persimmons, onions, kiwi, kale, and others. In addition, due to their increased safety, affordability, and practicality for oral administration, dietary flavonoids are the focus of intense research. The configuration, quantity, and kind of hydroxyl groups it contains in relation to functional groups in the nuclear structure determine its bioavailability, metabolism, and biological activity. Fisetin exerts its wide range of pharmacological activities by modulating various pathways, making it useful for diverse biological conditions. These pathways include PI-3 kinase/AKT/p38, TFEB and Nrf2, suppression of EGF-induced MMP-9 & sp-1 transcription, AKT/MAPK, JAK-STAT/NF-kB, MEK/ERK, COX-2/iNOS, NF-kB/p300/IKK, VEGFR1/p-ERK1/2/p38/pJNK, NF-κB/I-κBα, COX-2/WNT/EGFR/NF-κB, CDKN1B/P70S6K, PI3K/ AKT/CREB, PI3K/AKT/GSK3β, TLR4/NF-κB, and TXNIP/MAPKs, contributing to apoptotic cell death and potential therapeutic applications, making it a valuable molecule in various health contexts. Pleiotropic pharmacological properties of the polyphenol fisetin, make the molecule effective as antihyperalgesic, antileishmanial, anti-inflammatory, antidiabetic, antihypertensive & cardioprotective, anti-photo inflammatory, antiproliferative, anti-cancer drug and used in psoriasis, ACD, AMD, SCI, hair growth promoter, SLE, AOM, SS2 infections, UL, PVR, Huntington’s, Alzheimer’s diseases. This study explores the flavone molecule fisetin and its structural, chemical, biological, pharmacological, and molecular properties.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cms/10.2174/0126661454285734240311094827
2024-03-20
2025-12-07

  • From This Site

    /content/journals/cms/10.2174/0126661454285734240311094827
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. AlexievaI.N. PopovaA.T. MihaylovaD.S. Trends in herbal usage - A survey study.Food Res.20194250050610.26656/fr.2017.4(2).346
     [Google Scholar]
  2. KhanN. AfaqF. KhusroF.H. AdhamiV.M. SuhY. MukhtarH. Dual inhibition of Pi3k/Akt and mTOR signaling in human non-small cell lung cancer cells by a dietary flavonoid fisetin.Int. J. Cancer201213071695170510.1002/ijc.2617821618507
     [Google Scholar]
  3. KhanN. SyedD.N. AhmadN. MukhtarH. Fisetin: A dietary antioxidant for health promotion.Antioxid. Redox Signal.201319215116210.1089/ars.2012.490123121441
     [Google Scholar]
  4. KashyapD. GargV.K. TuliH.S. Fisetin and quercetin: Promising flavonoids with chemopreventive potential.Biomolecules20199517410.3390/biom905017431064104
     [Google Scholar]
  5. SundarrajK. RaghunathA. PerumalE. A review on the chemotherapeutic potential of fisetin: In vitro evidences.Biomed. Pharmacother.20189792894010.1016/j.biopha.2017.10.16429136771
     [Google Scholar]
  6. KumarS. PandeyA.K. Chemistry and biological activities of flavonoids: An overview.Sci World J201316275010.1155/2013/162750
     [Google Scholar]
  7. GrynkiewiczG. DemchukO.M. New perspectives for fisetin.Front Chem.2019769710.3389/fchem.2019.0069731750288
     [Google Scholar]
  8. ImranM. SaeedF. GilaniS.A. Fisetin: An anticancer perspective.Food Sci. Nutr.20219131610.1002/fsn3.187233473265
     [Google Scholar]
  9. LallR.K. AdhamiV.M. MukhtarH. Dietary flavonoid fisetin for cancer prevention and treatment.Mol. Nutr. Food Res.20166061396140510.1002/mnfr.20160002527059089
     [Google Scholar]
  10. KubinaR. IritiM. Kabała-DzikA. Anticancer potential of selected flavonols: Fisetin, kaempferol, and quercetin on head and neck cancers.Nutrients202113384510.3390/nu1303084533807530
     [Google Scholar]
  11. VelazhahanV. GlazaP. HerreraA.I. Dietary flavonoid fisetin binds human SUMO1 and blocks sumoylation of p53.PLoS One2020156e023446810.1371/journal.pone.023446832530958
     [Google Scholar]
  12. ZhaoX. WangC. CuiW.G. MaQ. ZhouW.H. Fisetin exerts antihyperalgesic effect in a mouse model of neuropathic pain: Engagement of spinal serotonergic system.Sci. Rep.201551904310.1038/srep0904325761874
     [Google Scholar]
  13. AdinehbeigiK. Razi JalaliM.H. ShahriariA. BahramiS. In vitro antileishmanial activity of fisetin flavonoid via inhibition of glutathione biosynthesis and arginase activity in Leishmania infantum.Pathog. Glob. Health2017111417618510.1080/20477724.2017.131277728385129
     [Google Scholar]
  14. ElsallabiO. PatrunoA. PesceM. CataldiA. CarradoriS. GalloriniM. Fisetin as a senotherapeutic agent: Biopharmaceutical properties and crosstalk between cell senescence and neuroprotection.Molecules202227373810.3390/molecules2703073835164003
     [Google Scholar]
  15. KimS. ChoiK.J. ChoS.C. Fisetin stimulates autophagic degradation of phosphorylated tau via the activation of TFEB and Nrf2 transcription factors.Sci. Rep.2016612493310.1038/srep2493327112200
     [Google Scholar]
  16. HodginK.S. DonovanE.K. Kekes-SzaboS. A placebo-controlled, pseudo-randomized, crossover trial of botanical agents for gulf war illness: Resveratrol (polygonum cuspidatum), luteolin, and fisetin (rhus succedanea).Int. J. Environ. Res. Public Health2021185248310.3390/ijerph1805248333802381
     [Google Scholar]
  17. ZhangY. ZongB. WangX. Fisetin lowers Streptococcus suis serotype 2 pathogenicity in mice by inhibiting the hemolytic activity of suilysin.Front. Microbiol.20189172310.3389/fmicb.2018.0172330105012
     [Google Scholar]
  18. XiaoS. LuY. WuQ. Fisetin inhibits tau aggregation by interacting with the protein and preventing the formation of β-strands.Int. J. Biol. Macromol.202117838139310.1016/j.ijbiomac.2021.02.21033662414
     [Google Scholar]
  19. KrasievaT.B. EhrenJ. O’SullivanT. TrombergB.J. MaherP. Cell and brain tissue imaging of the flavonoid fisetin using label-free two-photon microscopy.Neurochem. Int.20158924324810.1016/j.neuint.2015.08.00326271433
     [Google Scholar]
  20. ParkC. NohJ.S. JungY. Fisetin attenuated oxidative stress-induced cellular damage in arpe-19 human retinal pigment epithelial cells through Nrf2-mediated activation of heme oxygenase-1.Front. Pharmacol.20221392789810.3389/fphar.2022.92789835784747
     [Google Scholar]
  21. HyttiM. PiippoN. KorhonenE. HonkakoskiP. KaarnirantaK. KauppinenA. Fisetin and luteolin protect human retinal pigment epithelial cells from oxidative stress-induced cell death and regulate inflammation.Sci. Rep.2015511764510.1038/srep1764526619957
     [Google Scholar]
  22. GovindarajuV.K. BodasM. VijN. Cigarette smoke induced autophagy-impairment regulates AMD pathogenesis mechanisms in ARPE-19 cells.PLoS One2017128e018242010.1371/journal.pone.018242028767736
     [Google Scholar]
  23. PehoteG. BodasM. BruciaK. VijN. Cigarette smoke exposure inhibits bacterial killing via TFEB-mediated autophagy impairment and resulting phagocytosis defect.Mediators Inflamm.2017201711410.1155/2017/302808229445254
     [Google Scholar]
  24. LinH.Y. ChenY.S. WangK. ChienH.W. HsiehY.H. YangS.F. Fisetin inhibits epidermal growth factor-induced migration of ARPE-19 cells by suppression of AKT activation and Sp1-dependent MMP-9 expression.Mol. Vis.20172390091029296070
     [Google Scholar]
  25. CurraisA. FarrokhiC. DarguschR. Fisetin reduces the impact of aging on behavior and physiology in the rapidly aging SAMP8 mouse.J. Gerontol. A Biol. Sci. Med. Sci.201873329930710.1093/gerona/glx10428575152
     [Google Scholar]
  26. KammerudS.C. MetgeB.J. ElhamamsyA.R. Novel role of the dietary flavonoid fisetin in suppressing rRNA biogenesis.Lab. Invest.2021101111439144810.1038/s41374‑021‑00642‑134267320
     [Google Scholar]
  27. AfrozeN. PramodhS. ShafarinJ. Fisetin deters cell proliferation, induces apoptosis, alleviates oxidative stress and inflammation in human cancer cells, hela.Int. J. Mol. Sci.2022233170710.3390/ijms2303170735163629
     [Google Scholar]
  28. HsiehM.H. TsaiJ.P. YangS.F. Fisetin suppresses the proliferation and metastasis of renal cell carcinoma through upregulation of MEK/ERK-targeting CTSS and ADAM9.Cells20198994810.3390/cells809094831438640
     [Google Scholar]
  29. MinK. NamJ.O. KwonT. Fisetin induces apoptosis through p53-mediated up-regulation of DR5 expression in human renal carcinoma caki cells.Molecules2017228128510.3390/molecules2208128528767099
     [Google Scholar]
  30. MurtazaI. AdhamiV.M. HafeezB.B. Fisetin, a natural flavonoid, targets chemoresistant human pancreatic cancer AsPC‐1 cells through DR3‐mediated inhibition of NF‐κB.Int. J. Cancer2009125102465247310.1002/ijc.2462819670328
     [Google Scholar]
  31. SiY. LiuJ. ShenH. Fisetin decreases TET 1 activity and CCNY/CDK 16 promoter 5hmC levels to inhibit the proliferation and invasion of renal cancer stem cell.J. Cell. Mol. Med.20192321095110510.1111/jcmm.1401030411496
     [Google Scholar]
  32. ChamcheuJ.C. EsnaultS. AdhamiV.M. Fisetin, a 3,7,3҆,4҆ -Tetrahydroxy flavone inhibits the PI3K/Akt/] mTOR and MAPK pathways and ameliorates psoriasis pathology in 2D and 3D organotypic human inflammatory skin models.Cells20198108910.3390/cells809108931540162
     [Google Scholar]
  33. SyedD.N. ChamcheuJ.C. KhanM.I. Fisetin inhibits human melanoma cell growth through direct binding to p70S6K and mTOR: Findings from 3-D melanoma skin equivalents and computational modeling.Biochem. Pharmacol.2014893349360
     [Google Scholar]
  34. SongB. ShenX. ZhangS. ZhaoR. WangY. JiangM. Effects of fisetin on allergic contact dermatitis via regulating the balance of Th17/Treg in mice.Comput. Math. Methods Med.20221910.1155/2022/9222541
     [Google Scholar]
  35. CrocettoF. di ZazzoE. BuonerbaC. Kaempferol, myricetin and fisetin in prostate and bladder cancer: A systematic review of the literature.Nutrients20211311375010.3390/nu1311375034836005
     [Google Scholar]
  36. KhanN. AfaqF. SyedD.N. MukhtarH. Fisetin, a novel dietary flavonoid, causes apoptosis and cell cycle arrest in human prostate cancer LNCaP cells.Carcinogenesis20082951049105610.1093/carcin/bgn07818359761
     [Google Scholar]
  37. KhanN. AsimM. AfaqF. Abu ZaidM. MukhtarH. A novel dietary flavonoid fisetin inhibits androgen receptor signaling and tumor growth in athymic nude mice.Cancer Res.200868208555856310.1158/0008‑5472.CAN‑08‑024018922931
     [Google Scholar]
  38. LallR.K. SyedD.N. KhanM.I. Dietary flavonoid fisetin increases abundance of high-molecular-mass hyaluronan conferring resistance to prostate oncogenesis.Carcinogenesis201637991892810.1093/carcin/bgw07127335141
     [Google Scholar]
  39. AdhamiV.M. SyedD.N. KhanN. MukhtarH. Dietary flavonoid fisetin: A novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management.Biochem. Pharmacol.201284101277128110.1016/j.bcp.2012.07.01222842629
     [Google Scholar]
  40. SyedD. AdhamiV. KhanM. MukhtarH. Inhibition of Akt/mTOR signaling by the dietary flavonoid fisetin.Anticancer. Agents Med. Chem.2013137995100110.2174/1871520611313999012923293889
     [Google Scholar]
  41. SuhY. AfaqF. KhanN. JohnsonJ.J. KhusroF.H. MukhtarH. Fisetin induces autophagic cell death through suppression of mTOR signaling pathway in prostate cancer cells.Carcinogenesis20103181424143310.1093/carcin/bgq11520530556
     [Google Scholar]
  42. MukhtarE. AdhamiV.M. SiddiquiI.A. VermaA.K. MukhtarH. Fisetin enhances chemotherapeutic effect of cabazitaxel against human prostate cancer cells.Mol. Cancer Ther.201615122863287410.1158/1535‑7163.MCT‑16‑051527765854
     [Google Scholar]
  43. LiJ. GongX. JiangR. Fisetin inhibited growth and metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via PTEN/Akt/] GSK3β signal pathway.Front. Pharmacol.2018977210.3389/fphar.2018.0077230108501
     [Google Scholar]
  44. SunX. MaX. LiQ. Anti cancer effects of fisetin on mammary carcinoma cells via regulation of the PI3K/Akt/] mTOR pathway: In vitro and in vivo studies.Int. J. Mol. Med.201842281182010.3892/ijmm.2018.365429749427
     [Google Scholar]
  45. ChuangJ.Y. ChangP.C. ShenY.C. Regulatory effects of fisetin on microglial activation.Molecules20141978820883910.3390/molecules1907882024972270
     [Google Scholar]
  46. PalH.C. SharmaS. StricklandL.R. Fisetin inhibits human melanoma cell invasion through promotion of mesenchymal to epithelial transition and by targeting MAPK and NFκB signaling pathways.PLoS One201491e8633810.1371/journal.pone.008633824466036
     [Google Scholar]
  47. PalH.C. BaxterR.D. HuntK.M. Fisetin, a phytochemical, potentiates sorafenib-induced apoptosis and abrogates tumor growth in athymic nude mice implanted with BRAF-mutated melanoma cells.Oncotarget2015629282962831110.18632/oncotarget.506426299806
     [Google Scholar]
  48. PalH.C. DiamondA.C. StricklandL.R. Fisetin, a dietary flavonoid, augments the anti-invasive and anti-metastatic potential of sorafenib in melanoma.Oncotarget2016721227124110.18632/oncotarget.623726517521
     [Google Scholar]
  49. MolagodaI.M.N. JayasinghaJ.A.C.C. ChoiY.H. JayasooriyaR.G.P.T. KangC.H. KimG.Y. Fisetin inhibits lipopolysaccharide-induced inflammatory response by activating β-catenin, leading to a decrease in endotoxic shock.Sci. Rep.2021111837710.1038/s41598‑021‑87257‑033863923
     [Google Scholar]
  50. DingG. XuX. LiD. Fisetin inhibits proliferation of pancreatic adenocarcinoma by inducing DNA damage via RFXAP/KDM4A-dependent histone H3K36 demethylation.Cell Death Dis.2020111089310.1038/s41419‑020‑03019‑233093461
     [Google Scholar]
  51. XiaoY. LiuY. GaoZ. Fisetin inhibits the proliferation, migration and invasion of pancreatic cancer by targeting PI3K/AKT/mTOR signaling.Aging20211322247532476710.18632/aging.20371334821587
     [Google Scholar]
  52. RoyT. BoatengS.T. Banang-MbeumiS. Synthesis, inverse docking-assisted identification and in vitro biological characterization of Flavonol-based analogs of fisetin as c-Kit, CDK2 and mTOR inhibitors against melanoma and non-melanoma skin cancers.Bioorg. Chem.202110710459510.1016/j.bioorg.2020.10459533450548
     [Google Scholar]
  53. JiaS. XuX. ZhouS. ChenY. DingG. CaoL. Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways.Cell Death Dis.201910214210.1038/s41419‑019‑1366‑y30760707
     [Google Scholar]
  54. WangB. WangJ. ZhaoX.H. Bioactivity of two polyphenols quercetin and fisetin against human gastric adenocarcinoma AGS cells as affected by two coexisting proteins.Molecules2022279287710.3390/molecules2709287735566228
     [Google Scholar]
  55. XiaoX. ZouJ. FangY. Fisetin and polymeric micelles encapsulating fisetin exhibit potent cytotoxic effects towards ovarian cancer cells.BMC Complement. Altern. Med.20181819110.1186/s12906‑018‑2127‑729544480
     [Google Scholar]
  56. SuhY. AfaqF. JohnsonJ.J. MukhtarH. A plant flavonoid fisetin induces apoptosis in colon cancer cells by inhibition of COX2 and Wnt/EGFR/NF- B-signaling pathways.Carcinogenesis200830230030710.1093/carcin/bgn26919037088
     [Google Scholar]
  57. KhanN. JajehF. EberhardtE.L. Fisetin and 5‐fluorouracil: Effective combination for PIK3CA ‐mutant colorectal cancer.Int. J. Cancer2019145113022303210.1002/ijc.3236731018249
     [Google Scholar]
  58. LiuY. CaoH. ZhaoY. ShanL. LanS. Fisetin-induced cell death in human ovarian cancer cell lines via zbp1-mediated necroptosis.J. Ovarian Res.20221515710.1186/s13048‑022‑00984‑435538559
     [Google Scholar]
  59. MauryaB.K. TrigunS.K. Fisetin modulates antioxidant enzymes and inflammatory factors to inhibit aflatoxin-B1 induced hepatocellular carcinoma in rats.Oxid. Med. Cell. Longev.201620161910.1155/2016/197279326682000
     [Google Scholar]
  60. ShihY.L. HungF.M. LeeC.H. Fisetin induces apoptosis of HSC3 human oral cancer cells through endoplasmic reticulum stress and dysfunction of mitochondria-mediated signaling pathways.In Vivo20173161103111410.21873/invivo.1117629102932
     [Google Scholar]
  61. LiY. JiaS. DaiW. Fisetin modulates human oral squamous cell carcinoma proliferation by blocking PAK4 signaling pathways.Drug Des. Devel. Ther.20201477378210.2147/DDDT.S22927032158195
     [Google Scholar]
  62. LiuX.F. LongH.J. MiaoX.Y. LiuG.L. YaoH.L. Fisetin inhibits liver cancer growth in a mouse model: Relation to dopamine receptor.Oncol. Rep.2017381536210.3892/or.2017.567628560391
     [Google Scholar]
  63. SunQ. ZhangW. ZhongW. SunX. ZhouZ. Dietary fisetin supplementation protects against alcohol-induced liver injury in mice.Alcohol. Clin. Exp. Res.201640102076208410.1111/acer.1317227575873
     [Google Scholar]
  64. HuangW. LiM.L. XiaM.Y. ShaoJ.Y. Fisetin-treatment alleviates airway inflammation through inhbition of MyD88/NF-κB signaling pathway.Int. J. Mol. Med.201842120821810.3892/ijmm.2018.358229568921
     [Google Scholar]
  65. WuS.J. HuangW.C. ChengC.Y. WangM.C. ChengS.C. LiouC.J. Fisetin suppresses the inflammatory response and oxidative stress in bronchial epithelial cells.Nutrients2022149184110.3390/nu1409184135565807
     [Google Scholar]
  66. CuiJ. FanJ. LiH. ZhangJ. TongJ. Neuroprotective potential of fisetin in an experimental model of spinal cord injury: Via modulation of NF-κB/IκBα pathway.Neuroreport202132429630510.1097/WNR.0000000000001596
     [Google Scholar]
  67. Klimaszewska-WiśniewskaA. Hałas-WiśniewskaM. GrzankaA. GrzankaD. Evaluation of anti-metastatic potential of the combination of fisetin with paclitaxel on A549 non-small cell lung cancer cells.Int. J. Mol. Sci.201819366110.3390/ijms1903066129495431
     [Google Scholar]
  68. OgawaM. UdonoM. TeruyaK. UeharaN. KatakuraY. Exosomes derived from fisetin-treated keratinocytes mediate hair growth promotion.Nutrients2021136208710.3390/nu1306208734207142
     [Google Scholar]
  69. SyedD.N. AfaqF. MaddodiN. Inhibition of human melanoma cell growth by the dietary flavonoid fisetin is associated with disruption of Wnt/β-catenin signaling and decreased Mitf levels.J. Invest. Dermatol.201113161291129910.1038/jid.2011.621346776
     [Google Scholar]
  70. WangL. CaoD. WuH. JiaH. YangC. ZhangL. Fisetin prolongs therapy window of brain ischemic stroke using tissue plasminogen activator: A double-blind randomized placebo-controlled clinical trial.Clin. Appl. Thromb. Hemost.20192510.1177/107602961987135931434498
     [Google Scholar]
  71. Le ́otoing L, Wauquier F, Guicheux J. The polyphenol fisetin protects bone by repressing NF-kB and MKP-1-dependent signaling pathways in osteoclasts.PLoS One201387e6838810.1371/journal.pone.006838823861901
     [Google Scholar]
  72. Dalle CarbonareL. BertaccoJ. GaglioS.C. Fisetin: An integrated approach to identify a strategy promoting osteogenesis.Front. Pharmacol.20221389069310.3389/fphar.2022.89069335652047
     [Google Scholar]
  73. KumariS. KambojA. WanjariM. SharmaA.K. Protective role of fisetin in STZ induced diabetic nephropathy in rats.J. Pharm. Res. Int.20213330B9711110.9734/jpri/2021/v33i30B31644
     [Google Scholar]
  74. ZhangS. XueR. GengY. WangH. LiW. Fisetin prevents HT22 cells from high glucose-induced neurotoxicity via PI3K/Akt/CREB signaling pathway.Front. Neurosci.20201424110.3389/fnins.2020.0024132265642
     [Google Scholar]
  75. DongW. JiaC. LiJ. Fisetin attenuates diabetic nephropathy-induced podocyte injury by inhibiting NLRP3 inflammasome.Front. Pharmacol.20221378370610.3389/fphar.2022.78370635126159
     [Google Scholar]
  76. MaherP. DarguschR. EhrenJ.L. OkadaS. SharmaK. SchubertD. Fisetin lowers methylglyoxal dependent protein glycation and limits the complications of diabetes.PLoS One201166e2122610.1371/journal.pone.002122621738623
     [Google Scholar]
  77. MaherP. DarguschR. BodaiL. GerardP.E. PurcellJ.M. MarshJ.L. ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington’s disease.Hum. Mol. Genet.201120226127010.1093/hmg/ddq46020952447
     [Google Scholar]
  78. OgbuaguN.E. AluwongT. AyoJ.O. SumanuV.O. Effect of fisetin and probiotic supplementation on erythrocyte osmotic fragility, malondialdehyde concentration and superoxide dismutase activity in broiler chickens exposed to heat stress.J. Vet. Med. Sci.201880121895190010.1292/jvms.18‑047730404955
     [Google Scholar]
  79. ShenB. ShangguanX. YinZ. Inhibitory effect of fisetin on α-glucosidase activity: kinetic and molecular docking studies.Molecules20212617530610.3390/molecules2617530634500738
     [Google Scholar]
  80. DingH. LiY. ChenS. Fisetin ameliorates cognitive impairment by activating mitophagy and suppressing neuroinflammation in rats with sepsis‐associated encephalopathy.CNS Neurosci. Ther.202228224725810.1111/cns.1376534837343
     [Google Scholar]
  81. ZhangH. ZhangH. WuX. GuoY. ChengW. QianF. Fisetin alleviates sepsis-induced multiple organ dysfunction in mice via inhibiting p38 MAPK/MK2 signaling.Acta Pharmacol. Sin.202041101348135610.1038/s41401‑020‑0462‑y32661350
     [Google Scholar]
  82. RodiusS. de KleinN. JeantyC. Fisetin protects against cardiac cell death through reduction of ROS production and caspases activity.Sci. Rep.2020101289610.1038/s41598‑020‑59894‑432076073
     [Google Scholar]
  83. PeiF. PeiH. SuC. Fisetin alleviates neointimal hyperplasia via PPARγ/PON2 antioxidative pathway in SHR rat artery injury model.Oxid. Med. Cell. Longev.2021•••11510.1155/2021/6625517
     [Google Scholar]
  84. ShanmugamK. RavindranS. KurianG.A. RajeshM. Fisetin confers cardioprotection against myocardial ischemia reperfusion injury by suppressing mitochondrial oxidative stress and mitochondrial dysfunction and inhibiting glycogen synthase kinase 3β activity.Oxid. Med. Cell. Longev.20182018917343610.1155/2018/9173436
     [Google Scholar]
  85. ShanmugamK. BoovarahanS.R. PremP. SivakumarB. KurianG.A. Fisetin attenuates myocardial ischemia-reperfusion injury by activating the reperfusion injury salvage kinase (RISK) signaling pathway.Front. Pharmacol.20211256647010.3389/fphar.2021.56647033762932
     [Google Scholar]
  86. WuP.Y. LyuJ.L. LiuY.J. Fisetin regulates Nrf2 expression and the inflammation-related signaling pathway to prevent UVB-induced skin damage in hairless mice.Int. J. Mol. Sci.20171810211810.3390/ijms1810211828994699
     [Google Scholar]
  87. HadaY. UchidaH.A. WadaJ. Fisetin attenuates lipopolysaccharide-induced inflammatory responses in macrophage.BioMed Res Intern.20211810.1155/2021/5570885
     [Google Scholar]
  88. GruendlerR. HippeB. Sendula JengicV. PeterlinB. HaslbergerA.G. Nutraceutical approaches of autophagy and neuroinflammation in alzheimer’s disease: A systematic review.Molecules20202524601810.3390/molecules2524601833353228
     [Google Scholar]
  89. YousefzadehM.J. ZhuY. McGowanS.J. Fisetin is a senotherapeutic that extends health and lifespan.EBioMedicine201836182810.1016/j.ebiom.2018.09.01530279143
     [Google Scholar]
  90. LiP. ChenD. HuangY. Fisetin administration improves LPS-induced acute otitis media in mouse in vivo.Int. J. Mol. Med.201842123724710.3892/ijmm.2018.358529568876
     [Google Scholar]
  91. Rosado-RamosR. Godinho-PereiraJ. MarquesD. Small molecule fisetin modulates alpha–synuclein aggregation.Molecules20212611335310.3390/molecules2611335334199487
     [Google Scholar]
  92. Klimaszewska-WiśniewskaA. GrzankaD. CzajkowskaP. Cellular and molecular alterations induced by low dose fisetin in human chronic myeloid leukemia cells.Int. J. Oncol.20195561261127410.3892/ijo.2019.488931638196
     [Google Scholar]
  93. YenJ.H. WuP.S. ChenS.F. WuM.J. Fisetin protects PC12 cells from tunicamycin-mediated cell death via reactive oxygen species scavenging and modulation of Nrf2-driven gene expression, SIRT1 and MAPK signaling in PC12 cells.Int. J. Mol. Sci.201718485210.3390/ijms1804085228420170
     [Google Scholar]
  94. XuS.P. LiY.S. Fisetin inhibits pristine-induced systemic lupus erythematosus in a murine model through CXCLs regulation.Int. J. Mol. Med.20184263220323010.3892/ijmm.2018.390330272314
     [Google Scholar]
  95. SaitoY. MiyajimaM. YamamotoS. Accumulation of senescent neural cells in murine lupus with depression-like behavior.Front. Immunol.20211269232110.3389/fimmu.2021.69232134804003
     [Google Scholar]
  96. Fisetin induces apoptosis in uterine leiomyomas through multiple pathways.Sci. Rep.2020101799310.1038/s41598‑020‑64871‑y
     [Google Scholar]
  97. WangN. YaoF. LiK. Fisetin regulates astrocyte migration and proliferation in vitro.Int. J. Mol. Med.201739478379010.3892/ijmm.2017.289028204814
     [Google Scholar]
  98. GhoneimF.M. Abo-ElkhairS.M. ElsamanoudyA.Z. ShabaanD.A. Evaluation of endothelial dysfunction and autophagy in fibromyalgia-related vascular and cerebral cortical changes and the ameliorative effect of fisetin.Cells20211114810.3390/cells1101004835011610
     [Google Scholar]
  99. SalmelaA.L. PouwelsJ. VarisA. Dietary flavonoid fisetin induces a forced exit from mitosis by targeting the mitotic spindle checkpoint.Carcinogenesis20093061032104010.1093/carcin/bgp10119395653
     [Google Scholar]
  100. SyedD.N. AdhamiV.M. KhanN. KhanM.I. MukhtarH. Exploring the molecular targets of dietary flavonoid fisetin in cancer.Semin. Cancer Biol.201640-4113014010.1016/j.semcancer.2016.04.00327163728
     [Google Scholar]
  101. SechiM. LallR.K. AfolabiS.O. Fisetin targets YB-1/RSK axis independent of its effect on ERK signaling: Insights from in vitro and in vivo melanoma models.Sci. Rep.2018811572610.1038/s41598‑018‑33879‑w30356079
     [Google Scholar]
/content/journals/cms/10.2174/0126661454285734240311094827
Loading
Potential Biomolecule Fisetin: Molecular and Pharmacological Perspectives
Current Materials Science 18, 758 (2025); https://doi.org/10.2174/0126661454285734240311094827
/content/journals/cms/10.2174/0126661454285734240311094827
/content/journals/cms/10.2174/0126661454285734240311094827
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): apoptotic cell death; biological conditions; fisetin; Flavonoid; pathways; pharmacological

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test